NZ223805A - Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them - Google Patents

Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them

Info

Publication number
NZ223805A
NZ223805A NZ223805A NZ22380588A NZ223805A NZ 223805 A NZ223805 A NZ 223805A NZ 223805 A NZ223805 A NZ 223805A NZ 22380588 A NZ22380588 A NZ 22380588A NZ 223805 A NZ223805 A NZ 223805A
Authority
NZ
New Zealand
Prior art keywords
formula
optically active
compound
physiologically acceptable
active compound
Prior art date
Application number
NZ223805A
Other languages
English (en)
Inventor
Giovanni Carniel
Fabrizio Orzi
Giorgio Ceroni
Bruno Miorini
Pierluigi Griggi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NZ223805A publication Critical patent/NZ223805A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ223805A 1987-03-10 1988-03-09 Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them NZ223805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878705601A GB8705601D0 (en) 1987-03-10 1987-03-10 Oxo-isoindolinyl derivatives

Publications (1)

Publication Number Publication Date
NZ223805A true NZ223805A (en) 1990-11-27

Family

ID=10613660

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223805A NZ223805A (en) 1987-03-10 1988-03-09 Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them

Country Status (29)

Country Link
JP (1) JPH0759555B2 (fr)
KR (1) KR880011096A (fr)
CN (1) CN1017527B (fr)
AT (1) AT392068B (fr)
AU (1) AU605253B2 (fr)
BE (1) BE1003280A3 (fr)
CH (1) CH675419A5 (fr)
DE (1) DE3807595A1 (fr)
DK (1) DK168568B1 (fr)
ES (1) ES2006361A6 (fr)
FI (1) FI93725C (fr)
FR (1) FR2612185B1 (fr)
GB (2) GB8705601D0 (fr)
GR (1) GR1000515B (fr)
HU (1) HU201011B (fr)
IE (1) IE60565B1 (fr)
IL (1) IL85651A (fr)
IT (1) IT1227787B (fr)
MY (1) MY103898A (fr)
NL (1) NL8800575A (fr)
NO (1) NO174666C (fr)
NZ (1) NZ223805A (fr)
PH (1) PH26254A (fr)
PT (1) PT86933B (fr)
SE (1) SE500710C2 (fr)
SU (1) SU1731046A3 (fr)
UA (1) UA12840A1 (fr)
YU (1) YU46565B (fr)
ZA (1) ZA881686B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
CN100400633C (zh) * 2006-03-30 2008-07-09 中国日用化学工业研究院 一种手洗餐具洗涤剂及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154525A1 (de) * 1970-11-05 1972-06-15 Carlo Erba S.P.A., Mailand (Italien) Isoindolinderivate und Verfahren zu ihrer Herstellung
GB1344663A (en) * 1970-11-10 1974-01-23 Erba Carlo Spa Isoindoline compounds
US4010274A (en) 1973-07-27 1977-03-01 Carlo Erba Isoindoline derivatives having platelet anti-aggregating activity
JPS516959A (en) * 1974-07-04 1976-01-20 Wakamoto Pharma Co Ltd Isoindorinjudotaino seizohoho
US4400520A (en) * 1980-09-10 1983-08-23 Hisamitsu Pharmaceutical Co., Inc. Novel process for preparing isoindoline derivatives
IT1201408B (it) * 1985-03-22 1989-02-02 Montedison Spa Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi
JPH07120969B2 (ja) * 1989-03-30 1995-12-20 クラリオン株式会社 スペクトラム拡散変調装置

Also Published As

Publication number Publication date
FR2612185B1 (fr) 1992-08-28
CH675419A5 (fr) 1990-09-28
ZA881686B (en) 1989-11-29
SE500710C2 (sv) 1994-08-15
SE8800846L (sv) 1988-09-11
FI93725C (fi) 1995-05-26
FI881075A (fi) 1988-09-11
IT1227787B (it) 1991-05-07
FR2612185A1 (fr) 1988-09-16
IE880648L (en) 1988-09-10
IE60565B1 (en) 1994-07-27
AU605253B2 (en) 1991-01-10
GB8805631D0 (en) 1988-04-07
JPS63238058A (ja) 1988-10-04
YU46788A (en) 1990-04-30
PT86933A (pt) 1988-04-01
DK168568B1 (da) 1994-04-25
JPH0759555B2 (ja) 1995-06-28
HUT47247A (en) 1989-02-28
DK128988A (da) 1988-09-11
IL85651A0 (en) 1988-08-31
YU46565B (sh) 1993-11-16
IL85651A (en) 1991-07-18
ES2006361A6 (es) 1989-04-16
AT392068B (de) 1991-01-25
GR1000515B (el) 1992-07-30
NO174666C (no) 1994-06-15
PT86933B (pt) 1992-05-29
FI881075A0 (fi) 1988-03-09
UA12840A1 (uk) 1997-02-28
GB2204579B (en) 1991-01-30
NO881055L (no) 1988-09-12
FI93725B (fi) 1995-02-15
BE1003280A3 (fr) 1992-02-18
NL8800575A (nl) 1988-10-03
CN88101200A (zh) 1988-10-26
PH26254A (en) 1992-04-01
NO174666B (no) 1994-03-07
AU1267988A (en) 1988-09-08
DE3807595A1 (de) 1988-09-22
DK128988D0 (da) 1988-03-09
MY103898A (en) 1993-10-30
KR880011096A (ko) 1988-10-26
SU1731046A3 (ru) 1992-04-30
GR880100137A (en) 1989-01-31
CN1017527B (zh) 1992-07-22
NO881055D0 (no) 1988-03-09
GB2204579A (en) 1988-11-16
SE8800846D0 (sv) 1988-03-09
IT8819683A0 (it) 1988-03-08
ATA58988A (de) 1990-07-15
GB8705601D0 (en) 1987-04-15
HU201011B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
US6054482A (en) Lactam-free amino acids
US4837224A (en) (R)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions
JP2010138190A (ja) ミエロペルオキシダーゼ阻害剤としてのチオキサンチン誘導体
SK3842000A3 (en) Oral compositions of levosimendan
JPH02138262A (ja) 新規医薬活性１，２，３，４，４ａ，５，１０，１０ａ‐オクタヒドロ‐ベンゾ〔ｇ〕キノリン誘導体
US4789681A (en) Cytoprotective guanidine derivatives useful in ischemic diseases
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
AU605253B2 (en) Optically active oxo-isoindolinyl derivatives
JP4257573B2 (ja) Ｒ（＋）α−リポ酸の製造方法
US5451606A (en) Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment
JPH07267954A (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１ノナン−化合物、その製法及び抗不整脈剤
PL219269B1 (pl) Deuterowane pochodne katecholoaminy i ich zastosowanie oraz preparaty farmaceutyczne, zawierające te związki
EP0894794A1 (fr) Isomères optiques du clopérastine
US3086972A (en) Aza-thiaxanthene derivatives
GB2157684A (en) Triazolopyrimidines their preparation and use in medicine
EP0562796A1 (fr) Composés d'acides phénoxyacétiques et compositions médicinales les contenant
EP2722327A1 (fr) Phase cristalline de (3S, 3s') 4,4'-disulfanediylbis (acide 3-aminobutane 1-sulfonique) avec de la L-lysine
EP0155524A1 (fr) Composé omega-aryl-alkylthianyliques, leur procédé de préparation et produits pharmaceutiques les contenant
EP0183002B2 (fr) Dérivé de sel de 3-hydroxy-5-(hydroxyméthyl)-2-méthyl-isonicobinaldéhyde phosphate avec activité pharmaceutique
WO1994007870A1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique
CA2201779C (fr) Fabrication de levobupivacaine et de ses analogues a partir de l-lysine
JPH11512726A (ja) 塩基性、環状、光学活性のα−アミノ酸の連続的製造方法
JPH02101063A (ja) 光学活性キナルジン酸誘導体の製造方法
BE876094A (fr) Derives d'acides benzolphenoxyalcanoiques exercant une activite normolipemiante
JPS62132845A (ja) Ｎ，ｎ−二置換フエニルセリン誘導体及びそれを有効成分とする中枢神経系用剤